hematology and medical oncology | sciencenewsnet.in

Breaking News

Alcohol-Induced Blackouts May Be Linked to How a Person Drinks, Not Just How Much

Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms

American College of Physicians issues clinical recommendations for newer pharmacological treatments of adults with Type 2 diabetes

Newer antibiotics underprescribed for highly resistant infections

RCT finds calories may be more important than meal timing when it comes to weight loss

Chula Ranks No.1 in Thailand for 32 Subjects in the QS World University Rankings by Subject 2024

Researchers to share expertise at international conference on mine water, reclamation

Physical field technologies to improve extraction and quality of extracted juices

$4.7 million award to help researchers prevent adolescent alcohol use

Lightweight and flexible yet strong? Versatile fibers with dramatically improved energy storage capacity

19 Apr, 2024

NCCN Annual Congress on Hematologic Malignancies™ Returns to In-Person October 14–15, 2022 in New York City

September 27, 2022 sarah JonasFeature

The 2022 NCCN Annual Congress on Hematologic Malignancies™ (#NCCNhem22) is taking place Friday, October 14–Saturday, October 15, 2022 in New York City. All live sessions will also stream remotely through a virtual event platform.

Internationally Renowned Breast Cancer and HIV-Associated Malignancy Expert to Join Mount Sinai

June 8, 2021 sarah JonasAnnouncement

Mount Sinai Health System has recruited an internationally recognized expert in the management of breast cancer and HIV-associated malignancies, Joseph A. Sparano, MD, FACP, as Chief of Hematology and Medical Oncology and Deputy Director of The Tisch Cancer Institute (TCI). Dr. Sparano will also hold the Ezra M. Greenspan, MD Professorship in Clinical Cancer Therapeutics at the Icahn School of Medicine at Mount Sinai and will oversee the expansion of clinical and research capacities of the Division and TCI.